RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • A prospective, parallel group, open-labeled, comparative, multi-centric, active controlled study to evaluate the safety, tolerability and benefits of fixed dose combination of acarbose and metformin versus metformin alone in type 2 diabetes.

A prospective, parallel group, open-labeled, comparative, multi-centric, active controlled study to evaluate the safety, tolerability and benefits of fixed dose combination of acarbose and metformin versus metformin alone in type 2 diabetes.

Add to Collection
2010 Nov Others Fist_Author_Year_PM

Full Author : ['Jayaram, S', 'Hariharan, R S', 'Madhavan, R', 'Periyandavar, I', 'Samra, S S']
Journal Title : The Journal of the Association of Physicians of India
Chapter : Section3
Journal Year : 2010
Cited by : Not Available

OBJECTIVE: The present study was a prospective, parallel group, open-labeled, comparative, multicentric, active controlled study to evaluate the safety, tolerability and benefits of fixed dose combination of acarbose and metformin versus metformin alone i.....

Keywords : ["prospective parallel group openlabele comparative multicentric active control study", "metformin versus metformin alone", "fix dose combination", "type diabetes", "safety tolerability", "evaluate", "benefit", "acarbose"]